Fast endophilin-mediated endocytosis

Last updated
Receptor Mediated Endocytosis. Receptor Mediated Endocytosis.jpg
Receptor Mediated Endocytosis.

Fast endophilin-mediated endocytosis (FEME) is an endocytic pathway found in eukaryotic cells. FEME is a type of receptor mediated endocytosis however it does not require clathrin. [1] Instead, FEME is a clathrin-independent endocytic pathway that requires the activity of endophilins and dynamins. [1]

Contents

In Clathrin-dependent endocytic pathways, endosomes budding from the cell membrane into the cell will form in clathrin pits, and be coated by clathrin triskelions. In FEME however, endosomes form when coated by actin, and internalise endophilin A2.

Function and importance

Regulation of cell signaling

FEME allows the rapid endocytosis of receptors such as G-Protein Coupled Receptors (GPCRs) & Receptor Tyrosine Kinases. [1] [2] These receptors play an essential role in the regulation of cell signaling. After rapid endocytosis of these receptors via FEME, these receptors are sorted into endosomes to be either permanently destroyed or recycled back to the plasma membrane, which can influence whether or not the cell is desensitized for a long period of time. [3]

Cell migration

FEME may also play a role in cell migration. [2] The enrichment of endophilin on the leading edge of cells suggests that FEME could be involved in this mechanism. [2]

Key characteristics of FEME

According to an article titled "Molecular mechanism of Fast Endophilin-Mediated Endocytosis" published in the Biochemical Journal in 2020, there are 8 key characteristics of FEME. [1]

FEME is not constantly active

FEME is not a constantly ongoing process within the cell. [1] Instead, FEME is triggered when receptors are activated by their associated ligands. [1] This an activation occurs within a matter of seconds, hence the name fast endophilin-mediated endocytosis. [1]

Endophilin aggregation must occur before receptor activation

Endophilin must aggregate into "discrete clusters" on the plasma membrane of a cell before the receptors are activated in order for FEME to occur. [1] In other words, FEME will not occur when endophilin is not present, even if receptors are being activated. [4] If endophilin is not present, receptors will either accumulate on the cell surface or be transported into the cell using another type of endocytic pathway. [4]

FEME occurs at different locations of the cell

FEME notably occurs on the leading edge of cells, where it is associated with cell migration. [2] However, FEME is not restricted to the leading edge of cells. [1] [2] In cells with no leading edge, such as confluent cells, FEME can occur on the basal and dorsal surfaces of cells as well. [1] [2]

FEME carriers retain their endophilin coat after budding

FEME carriers are microscopic proteins located in the cytosol of a cell. [1] FEME carriers are pleiotropic, meaning that they this one protein has many effects on the characteristics of the cell. [1] FEME carriers retain their Endophilin coat until they fuse with early endosomes, which is a key difference from Clathrin-mediated endocytosis which loses its clathrin coat directly after budding. [1]

FEME transports a wide variety of cargoes

FEME is known to transport an array of 16 different cargoes to date. [1]

  1. β1 adrenergic receptors [1]
  2. α2a adrenergic receptors [1]
  3. Dopamine receptor 3 [1]
  4. Dopamine receptor 4 [1]
  5. Muscarinic Acetylcholine receptor 4 [1]
  6. EGFR [1]
  7. HGFR [1]
  8. VEGFR [1]
  9. PDGFR [1]
  10. NGFR [1]
  11. IGFR [1]
  12. Tetrameric IL2R [1]
  13. PlexinA1 [1]
  14. ROBO1 [1]
  15. Cholera toxins [1]
  16. Shiga toxins [1]

FEME membrane scission requires 3 different proteins

Membrane scission is the process by which the membrane of a budding vesicle is divided into two. [5] In the context of FEME, membrane scission requires the combined actions of Endophilin, Dynamin, and actin. [1]

FEME carriers move in a retrograde fashion

FEME carriers move backwards, or retrogradely, down microtubules. This process is "powered" by Dynein, an ATPase belonging to the AAA+ superfamily. [6] Dynein facilitates the intracellular transport of cargoes towards the minus end of the microtubule. [7] This process of moving towards the minus end is called retrograde transport, which is the opposite of anterograde transport, which moves toward the plus-end of a microtubule. [7]

Cdk5 & GSK4β regulate FEME

Cdk5 and GSK3β play an active role in the negative regulation of FEME. [1] Negative regulation occurs when the activation of one protein inhibits the action of another. When Cdk5 & GSK4β are activated, they inhibit the recruitment of Dynein. [1]

Mechanism

Alessandra Casamento and Emmanuel Boucrot break down the mechanism of FEME into 6 key concepts in their article titled "Molecular mechanism of Fast Endophilin-Mediated Endocytosis" published in the Biochemical Journal in 2020: Priming, Cargo Selection, Membrane Curvature and carrier formation, Membrane scission, Cytosolic Transport, and Regulatory mechanisms. [1]

Priming

Cargo selection

Membrane curvature and carrier formation

Membrane scission

Cytosolic transport

Regulatory mechanisms

Associated proteins

Receptor tyrosine kinases

Kinases are enzymes that add a phosphate to a protein, also known as phosphorylating a protein. [8] Kinases have antagonistic functions to phosphatases, which remove a phosphate from a protein. [8] Receptor tyrosine kinases are a family of proteins that facilitate communication between cells by utilizing tyrosine phosphorylation. [9] EGFR, HGFR, VEGFR, PDGFR, NGFR, IGFR are types of receptor tyrosine kinases that are associated with FEME. [2]

Endophilin, Lamellipodin and Mena cooperate to regulate F actin dependent EGF receptor endocytosis.

EGFR [2]

HGFR [2]

VEGFR [2]

PDGFR [2]

NGFR [2]

IGF1R [2]

Lipid phosphatases

Phosphatases are enzymes that remove a phosphate from a protein, also known as dephosphorylating a protein. [8] Phosphatases have antagonistic functions to kinases, which add a phosphate to a protein. [8] SHIP1 and SHIP2 are types of lipid phosphatases associated with FEME. [2] [10]

SHIP1 [2]

SHIP2 [2]

FEME and disease

A pseudo-atomic model of helical scaffolds formed by a truncated version of endophilin-B1. Endophilin-b1-helical-scaffold.png
A pseudo-atomic model of helical scaffolds formed by a truncated version of endophilin-B1.

Endophilin plays a crucial role in the regulation of various diseases. The inhibition of FEME has been indicated as potential treatment method for many types of cancers and other diseases. [1] In their article titled "Biology of Endophilin and it's role in disease" published in the Frontiers in Immunology journal in 2023, Lu-Qi Yang, An-Fang Huang, and Wang-Dong Xu highlight four major categories of diseases regulated by endophilins: Neurodegenerative diseases, cardiovascular diseases, autoimmune diseases, and tumors. [11]

There are many subtypes of Endophilin that are expressed in different organs. Endophilin A is essential for FEME and an important regulatory protein in eukaryotic cells. Endophilin B can induce disease by changing cell behavior via autophagy induction or by causing cell self-destruction, also known as apoptosis.

Subtype of EndophilinOrgan(s) the Subtype is Expressed in
Endophilin A1Brain Tissue
Endophilin A2Pancreas, Placenta, Prostate, Testicles, Uterus, etc.
Endophilin A3Brain & Testicular Tissues
Endophilin B1Heart, Skeletal Muscle, Kidney, & Placenta
Endophilin B2Skeletal Muscle, Adipose Tissue, Lungs, Brain, & Mammary Glands
Source: [11]

Neurodegenerative diseases

Alzheimer's and Parkinson's disease are both heavily regulated by the activation or silencing of Endophilin.

Cardiovascular diseases

Autoimmune diseases

Tumors

Activation of SHIP1 and SHIP2, proteins associated with FEME, has been shown to fight cancer by suppressing tumors. [10]

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 Casamento A, Boucrot E (June 2020). "Molecular mechanism of Fast Endophilin-Mediated Endocytosis". The Biochemical Journal. 477 (12): 2327–2345. doi:10.1042/bcj20190342. PMC   7319585 . PMID   32589750.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Boucrot, Emmanuel; Ferreira, Antonio P. A.; Almeida-Souza, Leonardo; Debard, Sylvain; Vallis, Yvonne; Howard, Gillian; Bertot, Laetitia; Sauvonnet, Nathalie; McMahon, Harvey T. (January 2015). "Endophilin marks and controls a clathrin-independent endocytic pathway" . Nature. 517 (7535): 460–465. Bibcode:2015Natur.517..460B. doi:10.1038/nature14067. ISSN   0028-0836. PMID   25517094. S2CID   4470056. Archived from the original on 2022-10-12. Retrieved 2022-10-11.
  3. ↑ Watanabe, Shigeki; Boucrot, Emmanuel (2017-08-01). "Fast and ultrafast endocytosis" . Current Opinion in Cell Biology. Cell Organelles. 47: 64–71. doi:10.1016/j.ceb.2017.02.013. ISSN   0955-0674. PMID   28391090.
  4. 1 2 Chan Wah Hak, Laura; Khan, Shaheen; Di Meglio, Ilaria; Law, Ah-Lai; Lucken-Ardjomande Häsler, Safa; Quintaneiro, Leonor M.; Ferreira, Antonio P. A.; Krause, Matthias; McMahon, Harvey T.; Boucrot, Emmanuel (September 2018). "FBP17 and CIP4 recruit SHIP2 and lamellipodin to prime the plasma membrane for fast endophilin-mediated endocytosis". Nature Cell Biology. 20 (9): 1023–1031. doi:10.1038/s41556-018-0146-8. ISSN   1476-4679. PMC   6122583 . PMID   30061681.
  5. ↑ Rossman, Jeremy S.; Lamb, Robert A. (2013-10-06). "Viral Membrane Scission". Annual Review of Cell and Developmental Biology. 29: 551–569. doi:10.1146/annurev-cellbio-101011-155838. ISSN   1081-0706. PMC   4286373 . PMID   24099087.
  6. ↑ Cho, Carol; Vale, Ronald D. (2012-01-01). "The mechanism of dynein motility: Insight from crystal structures of the motor domain". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. AAA ATPases: structure and function. 1823 (1): 182–191. doi:10.1016/j.bbamcr.2011.10.009. ISSN   0167-4889. PMC   3249483 . PMID   22062687.
  7. 1 2 Schnapp, B J; Reese, T S (1989-03-01). "Dynein is the motor for retrograde axonal transport of organelles". Proceedings of the National Academy of Sciences. 86 (5): 1548–1552. Bibcode:1989PNAS...86.1548S. doi: 10.1073/pnas.86.5.1548 . PMC   286735 . PMID   2466291.
  8. 1 2 3 4 Cheng, Heung-Chin; Qi, Robert Z.; Paudel, Hemant; Zhu, Hong-Jian (2011-12-13). "Regulation and Function of Protein Kinases and Phosphatases". Enzyme Research. 2011: 1–3. doi: 10.4061/2011/794089 (inactive 5 May 2025). ISSN   2090-0414. PMC   3238372 . PMID   22195276.{{cite journal}}: CS1 maint: DOI inactive as of May 2025 (link)
  9. ↑ Hubbard, Stevan R; Miller, W Todd (2007-04-01). "Receptor tyrosine kinases: mechanisms of activation and signaling". Current Opinion in Cell Biology. Cell regulation. 19 (2): 117–123. doi:10.1016/j.ceb.2007.02.010. ISSN   0955-0674. PMC   2536775 . PMID   17306972.
  10. 1 2 Fuhler, Gwenny M.; Brooks, Robert; Toms, Bonnie; Iyer, Sonia; Gengo, Elizabeth A.; Park, Mi-Young; Gumbleton, Matthew; Viernes, Dennis R.; Chisholm, John D.; Kerr, William G. (2011-10-19). "Therapeutic Potential of SH2 Domain-Containing Inositol-5′-Phosphatase 1 (SHIP1) and SHIP2 Inhibition in Cancer". Molecular Medicine. 18 (1): 65–75. doi:10.2119/molmed.2011.00178. ISSN   1528-3658. PMC   3269644 . PMID   22033675.
  11. 1 2 Yang, Lu-Qi; Huang, An-Fang; Xu, Wang-Dong (2023-12-05). "Biology of endophilin and it's role in disease". Frontiers in Immunology. 14. doi: 10.3389/fimmu.2023.1297506 . ISSN   1664-3224. PMC   10728279 . PMID   38116012.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.